PAD 133 (Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg)

Pill imprint PAD 133 has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for PAD 133 (Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg)

Hydrochlorothiazide and moexipril hydrochloride
Imprint:
PAD 133
Strength:
12.5 mg / 7.5 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Paddock Laboratories, Inc.
National Drug Code (NDC):
00574-0133
Inactive Ingredients:
lactose
magnesium oxide
crospovidone
magnesium stearate
povidone
silicon dioxide
hypromelloses
titanium dioxide
polyethylene glycol 400
ferric oxide red

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)